Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Bob Kronemyer
Start-Up Spotlight: Atlantic Therapeutics, Stimulating The Stress Incontinence Market With Vaginal Mesh Alternative
While controversy over vaginal mesh implants and the serious complications resulting from these devices eroding inside the patient continue unabated across the globe, one Irish company is looking to capitalize on this opportune time by offering a noninvasive solution to stress urinary incontinence. Atlantic Therapeutics has recently won the backing of European healthcare VCs, raising €15m in a Series A round.
Genetesis raised $1.2m in seed funding last year to advance development of its noninvasive, radiation-free tool to map the heart’s electrical activity and enable detection of any cardiac abnormalities. The company will initially market the technology for use in chest pain triage in the emergency room.
Originating from aerospace technology, Bio2 Technologies’ Vitrium biomaterial platform is designed for multiple applications across musculoskeletal surgery. The firm has already begun commercialization in the US and expects to get a CE mark later this year.
Founded and led by serial entrepreneur Amr Salahieh, Apama Medical is developing a system that aims to combine the advantages of two approaches for treating atrial fibrillation: point-by-point radiofrequency-based ablation and cryoballoon ablation.
Cardiac imaging software specialist Arterys has partnered with GE Healthcare to bring to market the first easy-to-use and comprehensive MRI tool for heart defects.
Enable Injections has developed a small wearable device that allows controlled delivery of biologic drugs – of small to potentially large volumes – while the patient continues with their daily life.